parkinson glutathione oxidative ipsc crispr Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease Frontiers | Development of CRISPR
Frontiers Development of CRISPR Cas9, spin off technologies and their application in model construction and potential therapeutic methods of Parkinson's disease CRISPR Cas9 assisted stem cell therapy in Parkinson's disease Biomaterials Research Human midbrain organoids: a powerful tool for advanced Parkinson's disease modeling and therapy exploration npj Parkinson's Disease The glutathione system in Parkinson's disease and its progression ScienceDirect
Pay in 4 interest-free payments of $6.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



